ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
Nirayu Private Limited, part of the Alembic Ltd promoter group, acquired 167,734 equity shares from the open market. This increases their stake by 0.06%.
Nirayu Private Limited, a Promoter Group entity, bought 65,981 Alembic shares on NSE/BSE for ₹69,66,311, raising its stake from 63.46% to 63.49%.
Alembic Ltd's promoter group, Nirayu Private Limited, acquired 1,20,609 equity shares from the open market. The purchase value amounts to approximately ₹1.22 Crore.
Nirayu Private Limited, part of the promoter group, purchased 9,495 equity shares of Alembic Ltd for ₹9.41 Lakh via market transactions.
Nirayu Private Limited, a promoter group entity, acquired 216,969 shares of Alembic Ltd via market purchase for ₹2.15 Crore on August 31, 2026.
Nirayu Private Limited, a promoter group entity, acquired 129,136 equity shares of Alembic Ltd through a market purchase. The transaction increases their stake by 0.05%.
Alembic Limited held its 119th Annual General Meeting on August 11, 2026, via video conferencing. Shareholders transacted ordinary and special business items during the meeting.
Alembic Ltd reported revenue from operations of ₹48.7 Cr (-2.2% YoY) and net profit of ₹64.9 Cr (+5.4% YoY) for Q1 FY27.
Alembic Ltd scheduled a Board Meeting for August 11, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026.
Alembic Ltd filed its quarterly shareholding pattern as of 30th June 2026. The report details the stake distribution among promoters, institutions, and public shareholders.
Alembic Limited submitted its Business Responsibility & Sustainability Report for FY 2025-26. The report details the company's ESG performance and sustainability initiatives across its business segments.
Alembic Limited fixed August 4, 2026, as the record date for dividend entitlement. Payment follows approval at the Annual General Meeting scheduled for August 11, 2026.
Alembic Limited submitted its 119th Annual Report for FY 2025-26. The 119th Annual General Meeting is scheduled for August 11, 2026.
Alembic Ltd will hold its 119th AGM on 11 Aug 2026 via video conference. agenda: approve FY‑2026 accounts, dividend, director re‑appointment and a Rs 2.1 Cr commission.
Alembic Limited issued reminder letters to physical shareholders for mandatory KYC and nomination updates per SEBI circulars. Shareholders are encouraged to dematerialize shares to ensure liquidity.
Alembic Limited recommended a final dividend of ₹2.4 per share for FY 2025-26. The record date for shareholder eligibility is August 4, 2026.
Alembic Ltd reported revenue from operations of ₹60 Cr (-0.5% YoY) and net profit of ₹67.1 Cr (-2.0% YoY) for Q4 FY26.
Alembic Ltd reported audited financial results for FY2026 and recommended a 120% dividend. The board approved both standalone and consolidated statements, reflecting steady operational performance.
Alembic Ltd's board will meet on May 19, 2026, to approve audited annual results and consider a dividend. This meeting follows the fiscal year end.
Alembic Pharmaceuticals Limited has announced record dates for two listed Commercial Papers totaling ₹300 Crore. The record dates are May 6, 2026, and May 28, 2026, for ISINs INE901L14CG4 and INE901L14CH2 respectively. This filing ensures administrative readiness for the upcoming maturity of these debt instruments.
Alembic Limited submitted the compliance certificate under Regulation 74(5) of SEBI Regulations for the quarter ended March 31, 2026. The certificate from MUFG Intime India confirms that security certificates received for dematerialisation were processed and listed on the exchanges within prescribed timelines.